Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

BVMF/R1DY34 stock hub

BVMF/R1DY34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/R1DY34is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

55.8B

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/R1DY34

In the news

Latest news · BVMF/R1DY34

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E22.8

P25 11.3P50 14.6P75 19.6

Trailing P/E16.1

P25 15.2P50 21.5P75 27.3

ROE16.1

P25 5.3P50 12.3P75 22.5

ROIC14.4

P25 7P50 12.5P75 22.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/R1DY34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

213

Groups with data

Currency

INR

Showing 213 of 213 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	BR
Employees	27,811
Employees Change	763%
Employees Change Percent	2.82
Enterprise value	BRL 55.2B
Exchange	Brazil Stock Exchange
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Last refreshed	2026-05-10
Market cap	BRL 55.8B
Price	BRL 11.08
Price currency	BRL
Rev Per Employee	762,238.32x
Sector	Healthcare
Sic	2834
Symbol	bvmf/R1DY34
Website	https://www.drreddys.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.21%
EV Earnings	15.93x
EV/EBIT	16x
EV/EBITDA	12.36x
EV/FCF	24.59x
EV/Sales	3.08x
FCF yield	4.02%
Forward P/E	22.76x
P/B ratio	2.42x
P/E ratio	16.1x
P/S ratio	2.63x
PE Ratio10 Y	29.15x
PE Ratio3 Y	18.66x
PE Ratio5 Y	24.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	19.22%
EBITDA Margin	24.52%
FCF margin	10.6%
Gross margin	55.18%
Gross Profit	BRL 11.7B
Gross Profit Growth	3.35%
Gross Profit Growth Q	-4.58%
Gross Profit Growth3 Y	13.05%
Gross Profit Growth5 Y	13.68%
Net Income	BRL 3.5B
Net Income Growth	5.42%
Net Income Growth Q	-14.4%
Net Income Growth3 Y	15.9%
Net Income Growth5 Y	21.63%
Pretax Margin	21.07%
Profit Margin	16.36%
Profit Per Employee	BRL 124,722
ROA	7.96
Roa5y	9.82
ROCE	16.42
ROE	16.1
Roe5y	17.03
ROIC	14.38
Roic5y	19.14

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-14.96%
Cagr3y	7.3%
Div CAGR3	-1.26%
EPS Growth	5.58
EPS Growth Q	-14.29
EPS Growth3 Y	15.85
EPS Growth5 Y	21.59
FCF Growth	237.35%
FCF Growth3 Y	0.76%
FCF Growth5 Y	14.5%
OCF Growth	75.53%
OCF Growth Q	64.77%
OCF Growth10 Y	4.09%
OCF Growth3 Y	9.31%
OCF Growth5 Y	18.52%
Revenue Growth	11.09x
Revenue Growth Q	4.41x
Revenue Growth3 Y	13.38x
Revenue Growth5 Y	13.11x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.66
Assets	BRL 34.5B
Cash	BRL 5.1B
Current Assets	BRL 15.5B
Current Liabilities	BRL 8.2B
Debt	BRL 4.2B
Debt EBITDA	BRL 0.79
Debt Equity	BRL 0.18
Debt FCF	BRL 1.85
Equity	BRL 23B
Interest Coverage	19.91
Liabilities	BRL 11.5B
Long Term Assets	BRL 19B
Long Term Liabilities	BRL 3.2B
Net Cash	BRL 910.7M
Net Cash By Market Cap	BRL 1.63
Net Cash Growth	68.12%
Net Debt EBITDA	BRL -0.18
Net Debt Equity	BRL -0.04
Net Debt FCF	BRL -0.41
Tangible Book Value	BRL 15.8B
Tangible Book Value Per Share	BRL 18.97
WACC	5.76

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.88
Inventory Turnover	2.06
Net Working Capital	BRL 6.9B
Quick ratio	1.18
Working Capital	BRL 8.5B
Working Capital Turnover	BRL 0.16

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.15%
Dividend Growth	-11.95%
Dividend Growth Years	0%
Dividend per share	BRL 0.06
Dividend Years	4
Dividend Yield	0.57%
Ex Div Date	2025-07-09
Last Dividend	BRL 0.06
Payout Frequency	Annual
Payout Ratio	11.77%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-14.95%
3Y total return	23.56%
50-day SMA	12.81
All Time High	16.34
All Time High Change	-32.2%
All Time High Date	2024-07-29
All Time Low	9.1
All Time Low Change	21.73%
All Time Low Date	2023-01-12
ATR	0.29
Beta	0.3
Ch YTD	-7.36
High	11.08
High52	14.13
High52 Date	2025-06-17
High52ch	-21.59%
Low	11.08
Low52	10.8
Low52 Date	2026-04-15
Low52ch	2.59%
Ma50ch	-13.48%
RSI	34.74
RSI Monthly	48.92
RSI Weekly	44.52
Sharpe ratio	0.89x
Sortino ratio	1.71
Total Return	0.72%
Tr YTD	-7.36
Tr1m	-6.26%
Tr3m	-4.65%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL 4.1B
Operating Income Growth	-4.73
Operating Income Growth Q	-23.4
Operating Income Growth3 Y	10.35
Operating Income Growth5 Y	15.67
Operating margin	19.22

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	599,497,266%
Net Borrowing	293,887,646.7
Shares Insiders	26.74%
Shares Institutions	63.42%
Shares Qo Q	0%
Shares Yo Y	-0.15%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 2.2B
Average Volume	287.25x
Bv Per Share	27.42
CAPEX	BRL -1.6B
Ch1m	-6.26
Ch1y	-15.36
Ch3m	-4.65
Ch3y	21.41
Ch6m	-12.06
Change	0%
Change From Open	0
Close	0
Depreciation Amortization	954,159,042.9
Dollar Volume	11.08
Earnings Date	2026-05-12
EBIT	BRL 4.1B
EBITDA	BRL 5.2B
EPS	BRL 4.16
F Score	4
FCF	BRL 2.2B
FCF EV Yield	4.07x
Financing CF	-375,080,008
Fiscal Year End	March
Founded	1,984
Goodwill	645,855,444.7
Graham Number	8.41305
Graham Upside	-24.07
Income Tax	BRL 1B
Investing CF	-3,207,519,463
Is Primary Listing	0
Last Earnings Date	2026-01-21
Last Report Date	2025-12-31
Last Split Date	2024-11-05
Last Split Type	Forward
Lynch Fair Value	BRL 14.89
Lynch Upside	34.38
Ma20	12.11
Ma20ch	-8.5%
Net CF	344,798,994
Next Earnings Date	2026-05-12
Open	11.08
P FCF Ratio	24.85
P OCF Ratio	14.44
Payment Date	2025-08-12
Ppne	6,013,273,287.7
Price EBITDA	BRL 10.74
Ptbv Ratio	3.54
Relative Volume	0x
Revenue	21,198,609,960x
SBC By Revenue	0.1x
Share Based Comp	21,147,672
Tax By Revenue	4.84x
Tax Rate	22.98%
Tr6m	-12.06%
Volume	1
Z Score	5.49

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BVMF/R1DY34 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.6%

$0.06 annual per share

Payout ratio

+11.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+0.7%

Next ex-dividend date: 2025-07-09

Performance

BVMF/R1DY34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/R1DY34?

Insider, institutional, and short-interest positioning.

Institutional ownership

+63.4%

Share of float held by funds and institutions

Insider ownership

+26.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.2%

Negative means the company is buying back shares.

Technical

BVMF/R1DY34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

34.7

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

0.30

Less volatile than the market

Sharpe ratio

0.89

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/R1DY34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/R1DY34 stock rating?

bvmf/R1DY34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/R1DY34 analysis?

The full report lives at /stocks/bvmf/R1DY34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/R1DY34?

The latest report frames bvmf/R1DY34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/R1DY34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.